.jpg?#)
Nifty Pharma Underperforms In 2025, Highlighting Stock-Picker's Market
With most big names failing to impress, the year turned into a classic stock-picker's game, proof that even in a dull market, the right pills can still cure portfolios.
With most big names failing to impress, the year turned into a classic stock-picker's game, proof that even in a dull market, the right pills can still cure portfolios.
What's Your Reaction?
